华资实业(600191.SH)拟设立包头恒鲁生物科技有限公司

Core Viewpoint - The company plans to establish a wholly-owned subsidiary, Baotou Henglu Biotechnology Co., Ltd., with a registered capital of 10 million yuan to advance its development strategy of "innovation-driven, diversified layout, and promoting industrial upgrading" [1] Group 1: Company Strategy - The establishment of the new subsidiary aims to enhance the company's product offerings, including the development of skincare products using xanthan gum and convenient nutritional meal replacement products utilizing resistant dextrin [1] - The new product development is expected to extend the company's industrial chain and enhance the value chain of its products [1] Group 2: Technological Collaboration - The subsidiary will leverage existing resources such as the Baotou Huazi Synthetic Biology and Microbial Modification Technology Academician Workstation and the collaborative "Technology Demonstration Base" and "Co-Creation Base" with the Chinese Academy of Sciences [1] - The company plans to collaborate with industry experts, scholars, and research institutions to stay updated on cutting-edge technologies and industry trends in biological fermentation and health products [1]